Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Marek Grygier , , Start date: Nov 27, 2024

Electrophysiology & Arrhythmia

Intervention
Shortened Dual Antiplatelet Therapy
Author(s): Kevin S Tang , Shoujit Banerjee , George Tang , et al Added: 1 year ago

Anticoagulation

Intervention
The Role of Coronary Sinus Reducer Implantation for Refractory Angina
Author(s): Kevin Cheng , Jonathan M Hill , Ranil de Silva Added: 11 months ago

Intervention

Prevention & Chronic Conditions
Author(s): Billy A Caceres Added: 1 year ago
Dr Billy A Caceres (Columbia University School of Nursing, US), a renowned expert and lead author, recently discussed findings from the study titled "Differences in Ideal Cardiovascular Health Between Sexual Minority and Heterosexual Adults" published in JAMA Cardiology. The study aimed to determine whether there are disparities in cumulative cardiovascular health (CVH) scores between sexual… View more

Demographic
SCAI 25: Insights from the TRITAVI Registry
Author(s): Francesco Pelliccia Added: 1 month ago
SCAI 2025 - Insights from antiplatelet therapy after transcatheter aortic valve replacement (TAVR) show patients who received single antiplatelet treatment had significantly lower rates of overall six-month mortality, CV death and non-CV death compared to those treated with double antiplatelet treatment.Dr Francesco Pelliccia (Sapienza University of Rome, Rome, IT) joins us to discuss insights… View more

Anticoagulation

Intervention
LINC 2025: 12-Month Amputation and Readmission Rates from TRUE-PTX
Author(s): Marianne Brodmann Added: 4 months ago
LINC 2025 - 12-month amputation and readmission rates from the TRUE-PTX study suggests endovascular revascularisation for peripheral artery disease (PAD) with drug-eluting devices lead to better outcomes than with bare device therapies.Dr Marianne Brodmann (Medical University of Graz, AT) joins us to discuss the TRUE-PTX study evaluating a database of patients in the US with PAD who have recieved… View more

Vascular Disease and Surgery

Intervention
CRT 25: The PEERLESS Contraindication Cohort
Author(s): Stefan Stortecky Added: 3 months ago
CRT 25 - Outcomes in patients with intermediate-risk pulmonary embolism (PE) with contraindications to thrombolytics show large-bore mechanical thrombectomy is a safe and effective treatment option for this comorbid patient population. In the contraindication cohort, large-bore mechanical thrombectomy was successfully performed with no in-hospital mortality or intracranial haemorrhage.Dr Stefan… View more

Vascular Disease and Surgery
TCT 24: The TRISCEND II Trial
Author(s): Susheel Kodali Added: 7 months ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter tricuspid valve replacement (TTVR) compared to optimal medical therapy for patients with severe tricuspid regurgitation (TR).Dr Susheel Kodali (Columbia University Medical Center, New York, US) joins us onsite at TCT Conference to discuss the findings from the TRISCEND II Trial (NCT04482062; Edwards Lifesciences).TRISCEND II is a… View more

Intervention
AF, Stent and Anticoagulant
Author(s): Balen Abdulrahman , Richard J Jabbour , Nick Curzen Added: 2 years ago

Anticoagulation

Guidelines & Statements
ISET 2024
Start date: Jan 22, 2024 End date: Jan 25, 2024
For 36 years and counting, the International Symposium on Endovascular Therapy (ISET) has served as the cornerstone for experts to convene and engage in discussions and deliberations regarding cutting-edge techniques, groundbreaking technologies, and innovative procedures that continually elevate the standard of patient care.ISET's 2024 scientific sessions consist of 4 days of endovascular… View more

Intervention